What is GSK Plc ADR’s (NYSE:GSK) current market value? Can you beat the fundamentals?

In yesterday’s Wall Street session, GSK Plc ADR (NYSE:GSK) shares traded at $45.15, down -1.38% from the previous session.

GSK stock price is now 6.39% away from the 50-day moving average and 16.50% away from the 200-day moving average. The market capitalization of the company currently stands at $92.06B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’

In other news, GSK plc, 10% Owner bought 3,300,000 shares of the company’s stock on Dec 07 ’23. The stock was bought for $16,500,000 at an average price of $5.00. Upon completion of the transaction, the 10% Owner now directly owns 13,983,761 shares in the company, valued at $631.37 million. A total of 0.01% of the company’s stock is owned by insiders.

During the past 12 months, GSK Plc ADR has had a low of $33.33 and a high of $45.92. As of last week, the company has a debt-to-equity ratio of 1.28, a current ratio of 0.87, and a quick ratio of 0.58. According to the stock market information, the enterprise value for the company is $197187698688, which is based on a 16.42 price-to-earnings ratio, a 3.42 price-to-earnings-growth ratio, and a beta of 0.68. The fifty day moving average price for GSK is $42.4728 and a two-hundred day moving average price translates $38.80765 for the stock.

The latest earnings results from GSK Plc ADR (NYSE: GSK) was released for 2024-03-31. The net profit margin was 14.62% and return on equity was 35.18% for GSK. The company reported revenue of $9.34 billion for the quarter, compared to $8.44 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.57 percent.

Related Posts